Clinicogenetic Study of Turkish Patients With Syndromic Craniosynostosis and Literature Review

Creative Commons License

Nur B., Pehlivanoglu S., Mıhçı E., Calıskan M., Demır D., Alper O. M., ...Daha Fazla

PEDIATRIC NEUROLOGY, cilt.50, sa.5, ss.482-490, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 50 Sayı: 5
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1016/j.pediatrneurol.2014.01.023
  • Dergi Adı: PEDIATRIC NEUROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.482-490
  • Anahtar Kelimeler: Apert syndrome, Crouzon syndrome, Pfeiffer syndrome, craniosynostosis, DHPLC, SAETHRE-CHOTZEN-SYNDROME, RECEPTOR 2 GENE, PFEIFFER-SYNDROME, CROUZON-SYNDROME, FGFR2 GENE, APERT-SYNDROME, MOLECULAR DIAGNOSIS, JAPANESE PATIENTS, MUTATIONS, EXPRESSION
  • Akdeniz Üniversitesi Adresli: Evet

Özet

BACKGROUND: Fibroblast growth factor receptor 2 mutations have been associated with the craniosynostotic conditions of Apert, Crouzon, Pfeiffer, Saethre-Chotzen, Jackson-Weiss, Beare-Stevenson cutis gyrata, and Antley-Bixler syndromes in various ethnic groups. METHODS: Thirty-three unrelated Turkish patients (12 with Apert syndrome, 14 with Crouzon syndrome, six with Pfeiffer syndrome, and one with Saethre-Chotzen syndrome) and 67 nonsyndromic craniosynostosis patients were screened for mutations in exons Ilia and IIIc of the FGFR2 gene by denaturing high-performance liquid chromatography and confirmed by direct sequencing. RESULTS: We detected several pathogenic mutations in 11/33 (33%) patients with Apert syndrome (four with p.Pro253Arg; seven with p.Ser252Trp) and 8/33 (24%) patients with Crouzon syndrome (three with p.Trp290Arg, one with p.Cys342Tyr, p.Cys278Phe, p.G1n289Pro, and a novel p.Tyr340Asn mutation) and five (15%) with Pfeiffer syndrome (p.Cys342Arg, p.Pro253Arg, p.Trp290Arg, and p.Ser351Cys). No FGFR2 gene mutation was detected in any of the patients with Saethre-Chotzen syndrome and nonsyndromic craniosynostosis. CONCLUSIONS: Our results indicate that the majority of Turkish patients with syndromic craniosynostosis have detectable genetic changes with an overall frequency of 72.7%. Because this is the first molecular genetic report from a Turkish cohort, the identified spectrum profile of FGFR2 mutations of the syndromic craniosynostotic patients would be very helpful for understanding the genotype phenotype relationship and has a great value for diagnosis, prognosis, and genetic counseling.